Market Place
Sourcing Support
J&J, Pfizer and Roche face FDA questions over data applicability
17 May 2025 //
FIERCE PHARMA
Roche questions US investment plans after Trump executive order
15 May 2025 //
FIERCE PHARMA
Genentech honors hemophilia A caregivers in Hemlibra short film
14 May 2025 //
FIERCE PHARMA
Roche boosts US presence with new $700M North Carolina facility
13 May 2025 //
REUTERS
Roche invests $550 million to expand Indianapolis hub
12 May 2025 //
PR NEWSWIRE
Roche puts up nearly $300M to expand manufacturing in China
10 May 2025 //
FIERCE PHARMA
CHMP recommends label update for Roche`s Phesgo
30 Apr 2025 //
GLOBENEWSWIRE
Roche nets FDA breakthrough label for AI lung cancer CDx test
29 Apr 2025 //
FIERCE BIOTECH
Roche profits 100 times more on Indian medicine, defends move
28 Apr 2025 //
ECONOMICTIMES
Tariffs make M&A decisions `more difficult,` says Roche CEO
24 Apr 2025 //
FIERCE BIOTECH
Roche works to mitigate US tariff impact with exemption
24 Apr 2025 //
FIERCE PHARMA
Roche reports 6% sales growth in Q1 2025
24 Apr 2025 //
GLOBENEWSWIRE
Roche gets CE Mark for Chest Pain Triage algorithm to detect of ACS
23 Apr 2025 //
GLOBENEWSWIRE
Roche to invest $50 billion in US over next five years
22 Apr 2025 //
REUTERS
Roche discontinues low dose in Huntington’s trial
19 Apr 2025 //
ENDPTS
Oak Hill Bio Licenses Angelman Syndrome Treatment to Roche
15 Apr 2025 //
BUSINESSWIRE
EU Commission OKs Roche`s Columvi as first bispecific antibody
14 Apr 2025 //
GLOBENEWSWIRE
Inka Health Publishes Roche-Sponsored Study on Oncology Research
10 Apr 2025 //
ACCESSWIRE
Roche`s Brainshuttle tech promises next-gen amyloid beta mAbs
08 Apr 2025 //
EXPRESSPHARMA
NATCO Pharma updates on legal proceedings for Risdiplam launch
08 Apr 2025 //
INDPHARMAPOST
Roche unveils Alzheimer`s advancements at AD/PD 2025
03 Apr 2025 //
GLOBENEWSWIRE
Genentech and Roche reveal Alzheimer`s advancements at AD/PD 2025
03 Apr 2025 //
BUSINESSWIRE
Roche`s high-dose version of Ocrevus flunks phase 3 trial
03 Apr 2025 //
FIERCE PHARMA
Roche Annual General Meeting 2025
25 Mar 2025 //
GLOBENEWSWIRE
Novartis & Roche ditch some diversity programmes on US concerns
20 Mar 2025 //
REUTERS
Roche doubles down on ADCs in $1B biobucks pact with Oxford Bio
19 Mar 2025 //
FIERCE BIOTECH
Roche to share neuromuscular advancements at MDA 2025 conference
17 Mar 2025 //
GLOBENEWSWIRE
Roche settles UPenn patent lawsuit over breast cancer drugs
17 Mar 2025 //
FIERCE PHARMA
Roche pairs with Zealand Pharma on obesity drug candidate
12 Mar 2025 //
REUTERS
$2.4B gene therapy impairment sparks Roche restructure
11 Mar 2025 //
FIERCE PHRMA
Roche Launches Genentech Innovation Center In Boston
07 Mar 2025 //
GLOBENEWSWIRE
FDA Accepts sBLA For Genentech’s Gazyva In Lupus Nephritis
06 Mar 2025 //
BUSINESSWIRE
Roche/BioNTech vaccine shows early promise in pancreatic cancer
06 Mar 2025 //
REUTERS
Roche’s Xolair Doubles Success Rate In Food Allergy Trial
03 Mar 2025 //
BUSINESSWIRE
CHMP Recommends EU Approval Of Roche’s Columvi Combo For DLBCL
28 Feb 2025 //
GLOBENEWSWIRE
Immune-Onc Doses 1st Patient In IO-108 Ph 1b/2 Liver Study With Roche
27 Feb 2025 //
BUSINESSWIRE
Roche rolls out new DNA `sequencing-by-expansion` approach
22 Feb 2025 //
FIERCE BIOTECH
Roche Unveils Novel Sequencing By Expansion Technology
20 Feb 2025 //
GLOBENEWSWIRE
Newleos unveils with $93M and 4 ex-Roche programs
14 Feb 2025 //
FIERCE BIOTECH
FDA approves Roche’s Evrysdi tablet as first & only tablet for SMA
12 Feb 2025 //
GLOBENEWSWIRE
Novo’s Bispecific for Hemophilia Aces Phase III Pediatric Trial
08 Feb 2025 //
BIOSPACE
Roche’s Gazyva Shows Superiority in Lupus Nephritis in NEJM
07 Feb 2025 //
GLOBENEWSWIRE
FDA Approves Roche’s Susvimo in Diabetes-related Blindness
04 Feb 2025 //
GLOBENEWSWIRE
Roche Gets FDA Approval For HER2-Ultralow Breast Cancer Test
31 Jan 2025 //
GLOBENEWSWIRE
Roche`s Vabysmo crosses $4B mark as Polivy joins blockbuster club
31 Jan 2025 //
FIERCE PHARMA
Roche Pharma India to appoint Rajwinder as general manager
30 Jan 2025 //
ECONOMICTIMES
Roche Reports 7% Sales Growth In 2024, Q4 Sees 9% Growth Streak
30 Jan 2025 //
GLOBENEWSWIRE
Change to the Roche Enlarged Corporate Executive Committee
29 Jan 2025 //
GLOBENEWSWIRE
Roche Gets FDA 510(k) Nod For First Lp(a) Blood Test
29 Jan 2025 //
PR NEWSWIRE
Roche Itovebi Shows Survival Benefit In HR-Positive Breast Cancer
28 Jan 2025 //
GLOBENEWSWIRE
Roche`s Itovebi pads its case with overall survival win
28 Jan 2025 //
REUTERS
Roche Gets FDA Clearance, CLIA Waiver For cobas® liat STI Tests
22 Jan 2025 //
GLOBENEWSWIRE
Roche Gets FDA Clearance For Test To Diagnose B-Cell Lymphoma
13 Jan 2025 //
PR NEWSWIRE
Roche`s Chugai turns to Swiss biotech Araris for ADC deal
10 Jan 2025 //
FIERCE BIOTECH
Roche to complete $1.5 B acquisition of Poseida
09 Jan 2025 //
PRESS RELEASE
Roche projected to claim pharma`s 2025 sales crown
03 Jan 2025 //
FIERCE PHARMA
Innovent Enters into Agreement with Roche for Novel DLL3 ADC
02 Jan 2025 //
PR NEWSWIRE
Rapt pays $35M for challenger to Novartis, Roche drug
24 Dec 2024 //
FIERCE BIOTECH
Roche’s Prasinezumab Study Misses Primary Endpoint in PD
19 Dec 2024 //
GLOBENEWSWIRE
Roche`s Prothena-partnered Parkinson`s prospect fails phase 2b
19 Dec 2024 //
FIERCE BIOTECH
